Benign neoplasm: Lower jaw bone

CD2_BENIGN_BONE_LOWER_JAW

lip cancer: Tumors or cancer of the LIP.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D16.50&, D16.51& Hospital discharge: ICD-9 — 2131 Hospital discharge: ICD-8 — 21300 Cause of death: ICD-10 — D16.50&, D16.51& Cause of death: ICD-9 — 2131 Cause of death: ICD-8 — 21300 2 out of 7 registries used, show all original rules.	170
4. Check minimum number of events None	170
5. Include endpoints None	170
6. Filter based on genotype QC (FinnGen only)	159

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	CD2_BENIGN_BONE_LOWER_JAW
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D165
HD_ICD_9	2131
HD_ICD_8	21300
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D165
COD_ICD_9	2131
COD_ICD_8	21300
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Lower jaw bone based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	1354	749	590
Only index persons	1186	664	522
Unadjusted period prevalence (%)
Whole population	0.02	0.02	0.02
Only index persons	0.02	0.02	0.02
Median age at first event (years)
Whole population	40.31	42.78	36.91
Only index persons	37.44	40.64	33.38

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	159	97	62
Unadjusted period prevalence (%)	0.03	0.03	0.03
Median age at first event (years)	41.71	41.75	41.65

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
163: Matched controls
1630

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D16.50

ICD-10 Finland

Benign tumor of the mandibular bone or cartilage

+∞

78.7

D16.51

ICD-10 Finland

Benign tumor of the mandibular bone with urpsrung in teeth

+∞

66.3

EDA10

NOMESCO Finland

Biopsy of mandible

+∞

29.0

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

11.4

27.1

21300

ICD-8 Finland

Benign neoplasm of bone and cartilage, Mandibulae (detibus inclusis)

+∞

25.7

EFA10

NOMESCO Finland

Excision of lesion of jaws

+∞

22.4

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

8.0

22.3

EFA50

NOMESCO Finland

Excision of cyst of jaws

44.2

19.1

SAA04

NOMESCO Finland

Special examination of mouth

7.7

17.6

2131A

ICD-9 Finland

Benign neoplasm of bone and articular cartilage, Lower jaw bone

+∞

15.9

EDB00

NOMESCO Finland

Partial excision of mandible

+∞

14.8

D16.5

ICD-10 Finland

Benign neoplasm: Lower jaw bone

+∞

14.8

SAA03

NOMESCO Finland

Extended examination of mouth

3.7

14.6

102

511

EB1AI

NOMESCO Finland

Cone beam imaging of teeth and jaws (one quarter)

17.0

13.5

WZC00

NOMESCO Finland

Treatment plan or consultation

3.4

13.5

441

EBB10

NOMESCO Finland

Insertion of dental implant

54.7

13.1

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

4.2

11.5

104

EBA10

NOMESCO Finland

Operative extraction of tooth

3.7

11.3

143

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

23.4

10.9

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

4.5

8.4

K09.29

ICD-10 Finland

Cyst of jaw traumatic

47.3

7.8

K03.66

ICD-10 Finland

Tooth plaque

4.2

7.6

EDC45

NOMESCO Finland

Reconstruction of mandible using bone graft

+∞

7.3

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

6.9

7.2

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.4

6.9

495

K02.0

ICD-10 Finland

Caries limited to enamel

2.6

6.5

221

EBB15

NOMESCO Finland

Insertion of dental implant abutment

27.9

6.3

K09.02

ICD-10 Finland

Cyst lateral periodontal

+∞

6.3

4332

FHL

Lower jaw resection or tumor removal

+∞

6.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3020779) Urea [Moles/volume] in Serum or Plasma

110

2.62

4.34

6.4

8.1

8.53

8.80

mmol/l

0.07

104

(40768804) Tissue Pathology biopsy report

560

1.89

3.86

2.4

2.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

131

2.07

2.58

2.2

2.8

0.24

0.22

g/l

0.58

125

(40768797) Stomach Pathology biopsy report

187

1.88

2.44

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

6.40

2.39

1.0

1.4

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.16

2.38

8.8

10.5

23.39

25.02

mmol/l

1.90

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

360

1.65

2.22

2.6

2.1

2.65

2.78

mg/l

0.16

316

(3003458) Phosphate [Moles/volume] in Serum or Plasma

185

1.83

2.21

5.6

6.3

1.03

1.07

mmol/l

0.36

171

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2.67

2.12

1.4

1.6

—

(3010421) pH of Blood

2.67

2.12

2.2

3.7

7.42

0.11

(3045683) HLA typing for celiac disease panel - Blood or Tissue

5.12

2.08

1.0

—

(3000494) Fungus identified in Specimen by Culture

168

1.80

1.97

1.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

2.66

1.83

1.2

3.3

4.77

9.36

pmol/l

—

(3044640) Blood type and Crossmatch panel - Blood

466

1.53

1.82

2.6

2.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

273

1.62

1.77

1.6

1.8

451.38

49576726.11

pmol/l

0.50

236

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

3.93

1.73

1.4

1.6

13.28

18.41

ug/l

—

(3044290) Cell count panel - Cerebral spinal fluid

2.58

1.62

1.1

1.7

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

404

1.50

1.59

2.1

2.2

140.07

188.25

u/l

0.74

391

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

3.40

1.53

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

3.40

1.53

1.0

1.8

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2.30

1.49

2.9

2.4

24.24

24.46

mmol/l

—

(1616796) Gas panel - Central venous blood

2.48

1.41

2.6

3.0

—

(3042936) Bacteria identified in Isolate by Culture

219

1.57

1.40

1.4

2.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2.11

1.36

1.0

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.83

1.29

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

339

1.45

1.26

2.4

2.5

—

(3021440) Promyelocytes/Leukocytes in Blood

126

1.67

1.21

8.6

4.6

0.00

0.21

—

(3011648) Oxygen content in Venous blood

2.55

1.16

3.8

2.4

10.84

11.08

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

2.55

1.16

1.0

1.2

—

(3022806) Fractional oxyhemoglobin in Capillary blood

2.55

1.16

3.2

2.0

90.52

89.17

—

(3002256) Pathology report gross observation

196

1.52

1.12

1.3

—

(3013290) Carbon dioxide [Partial pressure] in Blood

2.24

1.09

2.9

3.3

4.66

4.92

kpa

—

(3027315) Oxygen [Partial pressure] in Blood

2.24

1.09

2.9

3.3

9.34

8.59

kpa

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

130

1.61

1.09

2.5

4.1

3.99

11.35

ug/l

1.24

103

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.85

1.08

1.5

1.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2.06

1.07

2.1

3.0

197.22

189.11

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

251

1.45

1.06

2.7

3.6

0.84

0.80

mmol/l

1.01

238

(3022145) Colonoscopy Study observation

157

1.54

1.03

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.98

0.0

1.3

—

28.89

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

2.21

0.98

1.4

2.1

3.03

6.38

u/ml

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

0.00

0.98

0.0

4.5

—

22.14

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

170

0.56

0.96

1.5

1.8

—

(3017181) Myelocytes/Leukocytes in Blood

135

1.55

0.94

8.6

4.4

0.38

0.80

—

(3026493) Urate [Moles/volume] in Serum or Plasma

339

1.36

0.92

3.7

3.2

359.57

336.13

umol/l

0.67

300

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

386

1.35

0.91

3.4

3.5

1490.04

1162.82

ng/l

0.26

328

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

673

1.30

0.91

2.9

2.8

—

estimate

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

120

1099

1.35

0.90

4.6

4.5

14.44

14.77

pmol/l

0.77

114

1012

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1.95

0.90

1.0

1.6

27.50

36.00

nmol/l

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1.95

0.90

1.3

—

(4035726) Immunohistochemistry procedure

120

1.56

0.90

1.2

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

521

1.31

0.87

3.9

3.8

24.49

29.27

ng/l

0.26

347

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1.97

0.85

3.2

4.9

0.30

0.38

iu/ml

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

513

1.30

0.84

3.0

3.3

52.92

31.79

u/l

0.53

489

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1.77

0.81

1.2

1.4

273.60

236.38

miu/ml

—

(40768443) Skin Pathology biopsy report

1.77

0.81

1.1

1.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

166

1.45

0.81

1.7

1.6

—

(3025159) Blasts/Leukocytes in Blood

132

1.50

0.80

9.4

5.1

0.00

0.41

—

(4094501) Cardiovascular stress test using bicycle ergometer

1.85

0.80

1.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

312

1.33

0.76

1.5

1.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

2.12

0.75

1.4

1.6

—

(3024928) Oxygen saturation in Venous blood

1.88

0.74

6.6

2.5

68.03

60.44

—

(3002179) Metamyelocytes/Leukocytes in Blood

126

1.48

0.74

9.1

4.5

0.00

0.55

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

152

1462

1.59

0.72

22.5

19.2

78.95

74.75

umol/l

0.44

152

1446

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1.95

0.71

1.0

1.6

0.68

0.52

nmol/l

—

(4024509) Urine culture

1.64

0.70

1.8

1.9

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

136

1285

1.35

0.70

4.5

4.1

1.36

1.29

mmol/l

0.41

128

1187

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

198

1.37

0.69

1.8

2.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1.70

0.69

6.9

3.5

72.19

48.29

mg/l

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1.70

0.69

6.7

3.5

24.89

27.88

mg/l

—

(1002224) Polysomnography panel

1.56

0.68

1.2

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

106

973

1.26

0.67

3.0

3.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

1.81

0.66

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.54

0.65

1.1

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

255

1.32

0.65

3.3

2.7

2.47

2.45

mmol/l

0.33

229

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

1.75

0.64

2.6

3.1

12.00

40.90

u/ml

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1.75

0.64

1.0

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1.66

0.63

1.9

2.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1.69

0.62

1.4

1.3

—

(44790048) Parainfluenza type 2 nucleic acid detection

0.00

0.61

0.0

1.9

—

(44790047) Parainfluenza type 1 nucleic acid detection

0.00

0.61

0.0

1.9

—

(44806118) Parainfluenza type 4 nucleic acid detection

0.00

0.61

0.0

1.9

—

(44790049) Parainfluenza type 3 nucleic acid detection

0.00

0.61

0.0

1.9

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

698

1.23

0.60

9.3

7.8

1.22

mmol/l

0.04

602

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.60

0.0

1.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.52

0.59

2.0

1.7

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.59

0.0

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

324

1.27

0.58

1.7

1.9

0.61

1.40

mg/l

2.13

254

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

371

1.25

0.58

1.4

0.38

1.07

u/ml

1.01

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1.74

0.58

1.2

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

622

1.22

0.58

9.1

7.5

1.21

1.22

mmol/l

0.28

578

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1.69

0.57

1.0

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1.69

0.57

1.3

1.7

—

(3003694) ABO and Rh group [Type] in Blood

429

1.24

0.57

1.4

1.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

251

1.29

0.56

1.2

1.4

0.99

8.82

u/ml

—

108

(3032080) INR in Blood by Coagulation assay

623

1.22

0.56

15.7

11.3

1.22

1.19

inr

0.14

519

(3019977) pH of Arterial blood

152

1.36

0.55

11.0

11.3

7.42

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.55

0.54

2.8

2.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

144

1385

1.34

0.53

17.8

15.3

25.18

22.63

mg/l

0.34

122

1107

(3023323) Follitropin [Units/volume] in Serum or Plasma

1.45

0.52

1.2

1.5

5.22

22.03

iu/l

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

127

1.38

0.52

1.3

1.6

—

(3023368) Bacteria identified in Blood by Culture

367

1.23

0.51

5.0

4.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1.46

0.51

11.2

3.9

22.08

24.53

mmol/l

2.81

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

138

1322

1.29

0.50

17.6

14.7

84.07

84.48

ml/min/173m2

0.07

130

1214

(3000492) Spirometry study

146

1.34

0.49

1.4

1.5

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1.54

0.49

1.3

2.9

0.00

g/l

—

(21494755) Public health laboratory ask at order entry panel

156

1.32

0.48

1.2

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.48

0.47

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1.46

0.47

1.1

1.8

—

(3021589) Normoblasts [#/volume] in Blood

672

1.19

0.46

14.8

11.9

0.00

e9/l

0.50

543

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

142

1369

1.29

0.46

5.9

5.5

2.66

2.76

mmol/l

0.79

133

1273

(3007566) Smooth muscle Ab [Titer] in Serum

1.42

0.45

1.6

1.1

—

87.14

—

(3034770) Mitochondria Ab [Titer] in Serum

1.39

0.44

1.6

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

205

1.26

0.42

1.8

1.6

—

(3023520) Reticulocytes [#/volume] in Blood

123

1.33

0.42

1.7

3.2

52.64

73.39

e9/l

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

481

1.18

0.42

3.4

2.36

mmol/l

0.04

445

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.41

0.0

4.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

202

0.77

0.39

1.1

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

217

1.24

0.38

1.9

2.3

—

(42870588) Differential panel, method unspecified - Blood

485

1.17

0.38

5.6

6.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

831

1.16

0.37

9.0

11.1

4.26

4.04

e9/l

0.34

731

(3014007) Fractional oxyhemoglobin in Arterial blood

1.36

0.37

14.6

15.3

95.47

93.41

1.09

(3020682) Albumin/Creatinine [Ratio] in Urine

429

1.17

0.35

4.6

4.1

18.33

10.75

mg/mmol

0.36

262

(3005719) IgG [Mass/volume] in Serum or Plasma

136

1.28

0.35

2.6

9.32

9.82

g/l

0.32

126

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1.34

0.35

14.6

14.9

0.49

0.67

0.62

(3049717) Cytology report of Urine Cyto stain

1.38

0.35

2.8

2.6

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1.38

0.35

1.5

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

137

1326

1.21

0.34

5.2

4.8

6.01

5.84

mmol/l

0.73

130

1222

(3011397) Hemoglobin [Presence] in Urine by Test strip

355

1.17

0.32

4.4

4.0

—

0.00

—

(3022096) Basophils/Leukocytes in Blood

689

1.14

0.31

8.1

6.5

0.60

0.67

0.58

657

(3018418) pH of Serum or Plasma

434

1.15

0.31

6.0

4.5

7.40

0.10

317

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

176

1.22

0.30

1.8

—

(3018095) Leukocytes [#/volume] in Urine

542

1.14

0.30

3.9

4.2

50.06

57.31

e6/l

0.07

379

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

139

1351

1.20

0.30

5.2

4.8

1.46

1.47

mmol/l

0.13

130

1253

(3019150) Specific gravity of Urine by Refractometry

352

0.85

0.30

5.1

3.9

1.02

kg/l

0.60

230

(40761536) Microorganisms panel - Urine sediment

121

1.26

0.29

3.1

3.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

247

0.83

0.29

3.1

0.69

0.93

e6/l

0.20

126

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1.24

0.29

1.4

—

(3015736) pH of Urine

632

1.13

0.29

3.8

3.5

6.25

6.24

0.04

363

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1.30

0.29

14.5

14.6

0.93

1.35

1.45

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.30

0.29

2.4

2.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

169

1.21

0.27

1.7

1.9

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

139

1354

1.18

0.27

5.3

4.9

4.56

4.67

mmol/l

0.66

131

1263

(3027008) Opiates [Presence] in Urine

0.68

0.26

6.2

1.7

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

596

1.12

0.26

2.4

2.1

106.71

97.23

pmol/l

1.16

290

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.27

0.25

2.2

1.5

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

143

1398

1.19

0.24

22.2

17.3

139.67

139.75

mmol/l

0.14

143

1371

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

115

1.24

0.24

3.1

43.80

66.84

ml/min/173m2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

144

1.20

0.23

9.6

7.4

—

(3006504) Eosinophils/Leukocytes in Blood

690

1.10

0.22

8.1

6.5

2.75

2.78

0.04

660

(40768793) Breast Pathology biopsy report

1.23

0.22

1.2

1.3

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

0.21

0.0

1.5

—

9.03

—

(3051651) Icteric interference index of Serum or Plasma

0.00

0.21

0.0

3.2

—

0.73

—

(40768441) Liver Pathology biopsy report

0.00

0.21

0.0

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

0.21

0.0

1.0

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

1116.20

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

8.4

—

0.62

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.21

0.0

4.7

—

1.20

—

(37208534) Antinuclear antibody arbitrary concentration in serum

0.00

0.21

0.0

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.00

0.21

0.0

2.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.00

0.21

0.0

2.3

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.9

—

60.40

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.3

—

(3038026) Centromere Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3000991) Gas panel - Venous blood

127

1.20

0.20

19.8

12.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

0.00

0.20

0.0

4.0

—

20.44

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

1.6

—

3.24

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

0.20

0.0

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.18

—

(3019069) Monocytes/Leukocytes in Blood

693

1.10

0.20

8.3

6.6

9.41

8.58

1.19

665

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1.21

0.20

1.3

1.8

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

153

1508

1.24

0.20

27.7

23.4

90.60

90.79

0.22

153

1495

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1.18

0.19

1.3

1.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1.16

0.19

4.3

1.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

447

1.10

0.19

3.0

0.00

estimate

-0.00

128

(3006315) Basophils [#/volume] in Blood

756

0.91

0.19

8.7

6.7

0.03

0.04

e9/l

0.80

654

(3012516) Albumin [Mass/volume] in Urine

418

1.11

0.19

4.0

3.4

100.94

62.80

mg/l

0.31

267

(40761511) CBC panel - Blood by Automated count

146

1435

1.17

0.19

15.7

13.4

—

(3007461) Platelets [#/volume] in Blood

153

1509

1.23

0.18

27.7

23.5

249.59

251.27

e9/l

0.12

153

1485

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.19

0.18

1.3

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

0.75

0.17

1.0

2.3

—

7988.72

u/l

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.76

0.17

1.0

1.1

1.50

1.58

g/l

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.74

0.17

1.0

1.1

0.84

0.96

g/l

—

(3010813) Leukocytes [#/volume] in Blood

153

1510

1.22

0.17

27.8

23.6

6.44

6.64

e9/l

0.66

153

1478

(3035941) MCH [Entitic mass]

153

1510

1.22

0.17

27.7

23.4

30.12

30.26

0.50

153

1497

(3026361) Erythrocytes [#/volume] in Blood

153

1510

1.22

0.17

27.8

23.5

4.48

4.51

e12/l

0.34

153

1480

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

153

1510

1.22

0.17

28.7

24.2

40.38

40.45

0.08

153

1495

(3007164) IgA [Mass/volume] in Serum or Plasma

342

1.11

0.17

1.5

2.26

2.23

g/l

0.05

209

(3019060) Gas panel - Arterial blood

1.12

0.16

2.9

4.2

—

(3030467) Casts [#/volume] in Urine by Automated count

402

1.09

0.16

2.7

3.3

0.20

0.32

e6/l

0.74

291

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1.22

0.16

4.6

3.0

1.81

1.34

—

(3022313) Gas panel - Capillary blood

1.16

0.15

1.9

3.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

141

1.15

0.14

2.7

3.5

—

(3009508) Creatinine [Moles/volume] in Urine

464

1.08

0.13

4.3

3.3

6.90

7.68

mmol/l

0.58

401

(3019198) Lymphocytes [#/volume] in Blood

768

0.93

0.13

8.6

6.7

1.61

1.89

e9/l

1.94

688

(3000963) Hemoglobin [Mass/volume] in Blood

153

1513

1.18

0.13

28.2

23.7

134.17

135.52

g/l

0.59

153

1497

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

107

0.83

0.13

1.2

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

317

1.09

0.13

2.1

—

(40758558) Short blood count panel - Blood

436

1.08

0.12

7.7

6.9

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

117

1194

0.93

0.12

23.3

19.3

13.70

13.53

0.85

117

1184

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

240

1.10

0.12

2.0

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

192

1.11

0.11

10.7

8.7

105.57

104.42

mmol/l

0.43

192

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

208

0.90

0.11

2.3

2.8

0.82

0.80

ug/l

0.06

128

(3001604) Monocytes [#/volume] in Blood

754

0.94

0.11

8.5

6.7

0.58

0.57

e9/l

0.15

655

(3013115) Eosinophils [#/volume] in Blood

777

1.06

0.10

8.1

6.8

0.19

e9/l

0.11

688

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

598

1.06

0.10

4.3

3.6

0.00

estimate

-0.00

135

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

519

1.06

0.09

3.1

3.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1.07

0.09

1.6

1.5

—

(3002582) Erythrocytes [#/volume] in Urine

480

1.06

0.09

3.1

3.4

10.15

168.54

e6/l

0.62

367

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.09

0.09

2.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.81

0.08

1.0

1.1

—

0.68

—

(3018010) Neutrophils/Leukocytes in Blood

701

1.05

0.08

8.3

6.5

57.79

57.60

0.04

677

(3000764) Benzodiazepines [Presence] in Urine

0.84

0.08

5.7

1.7

—

(3028300) Cannabinoids [Presence] in Urine

0.83

0.08

5.5

1.7

—

(3027944) Amphetamines [Presence] in Urine

0.82

0.08

7.7

1.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

132

1304

1.06

0.07

5.8

5.4

1.70

1.84

mu/l

0.94

126

1215

(3004588) Protein electrophoresis panel - Serum or Plasma

1.06

0.07

2.6

2.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

173

0.92

0.07

1.6

1.9

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

234

0.93

0.07

3.1

3.2

1.31

2.98

e6/l

1.01

113

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

587

0.96

0.07

2.0

1.9

1.27

1.36

mmol/l

0.44

504

(3037467) Urinalysis macro (dipstick) panel - Urine

947

0.96

0.06

4.1

4.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

278

1.05

0.05

1.7

—

(36660697) Celiac disease serology panel - Serum

120

1.09

0.05

1.1

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

109

0.91

0.04

8.8

4.0

148.90

77.47

ng/l

—

(3026008) Bacteria identified in Urine by Culture

409

1.04

0.03

2.8

3.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

211

1.05

0.03

1.5

1.7

1294.47

1199.80

nmol/l

0.15

157

(3029937) Albumin [Presence] in Urine by Test strip

430

0.97

0.03

5.2

3.9

0.00

estimate

-0.00

145

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

261

1.04

0.03

3.4

4.7

25.47

23.64

—

119

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

281

1.04

0.02

1.3

1.4

105.98

22.68

iu/ml

—

(3014051) Protein [Presence] in Urine by Test strip

441

1.03

0.02

2.7

3.0

—

0.25

—

(3025941) Bacteria identified in Stool by Culture

1.08

0.02

1.4

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

113

1.07

0.02

2.7

2.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

106

0.94

0.01

1.2

1.4

—

32.35

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

274

1.03

0.00

3.8

3.7

258.97

175.38

ng/l

0.14

195

(1761868) Lipid panel - Serum or Plasma

584

1.02

0.00

3.2

3.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

374

0.99

0.00

7.5

5.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

251

1.00

0.00

1.5

—

(3009261) Glucose [Presence] in Urine by Test strip

792

1.00

0.00

4.3

3.9

0.00

estimate

-0.00

152

(3035350) Ketones [Presence] in Urine by Test strip

784

0.99

0.00

4.4

3.9

0.00

10.02

estimate

0.50

162

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.8

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.8

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.96

0.00

1.8

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

0.00

0.0

1.8

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.8

—

(40765096) Chromosome analysis panel by Banding

0.00

0.0

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

0.97

0.00

7.3

4.6

1.99

1.32

mg/l

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

0.0

1.4

—

30.84

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

0.0

1.9

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

0.00

0.0

1.3

—

71.44

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

0.96

0.00

2.8

2.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

0.00

0.0

35.8

—

106.38

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

0.00

-0.00

0.0

1.0

—

2.14

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.00

-0.00

1.1

1.0

—

(40757494) Bilirubin.total [Moles/volume] in Blood

0.00

-0.00

0.0

2.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.3

—

3.84

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

0.96

-0.00

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.00

-0.00

0.0

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

8.10

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

0.00

-0.00

0.0

1.3

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

93.78

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

-0.00

0.0

1.3

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

0.00

-0.00

0.0

1.0

—

47.40

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.00

-0.00

0.0

7.2

—

10.40

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1.02

-0.00

1.4

1.2

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

28.16

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

0.00

-0.00

0.0

1.2

—

5.86

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.02

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1.02

-0.00

1.4

1.2

—

(3020650) Glucose [Presence] in Urine

0.00

-0.00

0.0

1.1

—

0.00

—

(3002619) Bacteria identified in Specimen by Culture

0.00

-0.00

0.0

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

1.02

-0.00

1.4

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

0.86

-0.00

6.2

1.8

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.6

—

69.20

—

(3016879) Cocaine [Presence] in Urine

0.89

-0.00

5.5

1.8

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.6

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

-0.00

0.0

2.2

—

0.55

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

-0.00

0.0

3.6

—

44.40

—

(40758292) HTLV I+II Ab panel - Serum

0.00

-0.00

0.0

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

0.86

-0.00

1.6

2.2

—

(3011288) Drugs identified in Urine by Screen method Nominal

0.91

-0.00

9.8

2.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

(3012565) Volume of 24 hour Urine

0.00

-0.00

0.0

2.2

—

2260.00

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

0.33

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1.00

-0.00

1.2

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

0.99

-0.00

5.4

3.0

0.46

0.60

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

-0.00

0.0

1.0

—

6.29

—

(3021601) Nitrite [Presence] in Urine by Test strip

780

1.00

-0.00

4.4

3.8

0.00

estimate

-0.00

157

(3017704) Immunofixation for Urine

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_BONE_LOWER_JAW and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_BONE_LOWER_JAW.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_BONE_LOWER_JAW – Benign neoplasm: Lower jaw bone

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Lower jaw bone

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints